24 results  1 of 2 

1 Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat
Obstet Gynecol Sci.2022;65(5):459-467.   Published online 2022 July 29     DOI: http://dx.doi.org/10.5468/ogs.22102
      
2 Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257.   Published online 2022 July 19     DOI: http://dx.doi.org/10.4143/crt.2022.232
      
3 Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Cancer Res Treat.2022;54(4):1219-1229.   Published online 2021 November 17     DOI: http://dx.doi.org/10.4143/crt.2021.1010
      
4 Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang, Na Li, Yu-Lan Cui
Cancer Res Treat.2020;52(3):798-814.   Published online 2020 March 3     DOI: http://dx.doi.org/10.4143/crt.2019.498
      
5 Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Tae-Heon Kim, Haeyoun Kang, Hee Jung An
Cancer Res Treat.2020;52(2):634-644.   Published online 2020 January 6     DOI: http://dx.doi.org/10.4143/crt.2019.207
      
6 Assessment of solid components of borderline ovarian tumor and stage I carcinoma: added value of combined diffusion- and perfusion-weighted magnetic resonance imaging
See Hyung Kim
Yeungnam Univ J Med.2019;36(3):231-240.   Published online 2019 June 13     DOI: http://dx.doi.org/10.12701/yujm.2019.00234
      
7 A Case of Malignant Pleural Effusion Treated by Chemical Pleurodesis in Ovarian Carcinoma
Sang Hun Han, In Hwa No, Tae Youl Hwang, Pyo Hong, Kil Ung Choi, Jeong Hun Lee, Soo Kee Min, Ji Young Lee, Sook Cho, Woo Young Lee
Korean J Gynecol Oncol Colposc.2001;12(2):147-151.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.2001.12.2.147
      
8 Assessment of Gynecologic Malignancy (Recurrent Ovarian Carcinoma) by Positron Emission Tomography
Soon Beom Kang, Chul Min Lee, Yong Beom Kim, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, June Key Chung, Hyo Pyo Lee
Korean J Gynecol Oncol Colposc.1998;9(4):427-434.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.1998.9.4.427
      
9 c-erbB-2 Oncoprotein Assay in Ovarian Carcinoma and Its Clinical Correlation with Prognostic Factors
Young Tae Kim, Sung Eun Moon, Jae Wook Kim, Jung Woon Lee
Korean J Gynecol Oncol Colposc.1998;9(1):55-61.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.1998.9.1.55
      
10 Ovarian carcinoma initially presenting as enlargement of axillary lymph node
Chun June Lee, Chang Wan Joen
Korean J Gynecol Oncol.2006;17(3):241-245.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2006.17.3.241
      
11 The Ability of Preoperative Serum CA-125 level to Predict the Outcome of Primary Cytoreductive Surgery of Epithelial Ovarian Carcinoma
Han Moie Park, Yoon Soo Kim, Eun Kyoung Shin, Mi Kyoung Kim, Kyung Ah Jung, Mi Hye Park, Sun Hee Chun, Jung Ja Ahn, Chong Il Kim, Seung Cheol Kim
Korean J Gynecol Oncol Colposc.2003;14(2):158-166.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.2.158
      
12 Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
Ji Hui Choi, Geum Seon Sohn, Doo Byung Chay, Han Byoul Cho, Jae-Hoon Kim
Obstet Gynecol Sci.2018;61(3):344-351.   Published online 2018 May 2     DOI: http://dx.doi.org/10.5468/ogs.2018.61.3.344
      
13 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
E Sun Paik, Ji Hye Kim, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
J Gynecol Oncol.2018;29(1):e13.  Published online 2017 November 9     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e13
      
14 A Case of Metastatic Tracheal Tumor From Ovarian Carcinoma
Cheon Woong Choi, Jee Hong Yoo, Hye Lim Oh, Yongseon Cho, Hong Mo Kang
Tuberc Respir Dis.2001;50(4):499-503.   Published online 2016 March 9     DOI: http://dx.doi.org/10.4046/trd.2001.50.4.499
      
15 Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan
Ying-Cheng Chiang, Chi-An Chen, Chun-Ju Chiang, Tsui-Hsia Hsu, Ming-Chieh Lin, San-Lin You, Wen-Fang Cheng, Mei-Shu Lai
J Gynecol Oncol.2013;24(4):342-351.   Published online 2013 October 2     DOI: http://dx.doi.org/10.3802/jgo.2013.24.4.342
      
16 The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
Emma L. Barber, Emese Zsiros, John R. Lurain, Alfred Rademaker, Julian C. Schink, Nikki L. Neubauer
J Gynecol Oncol.2013;24(3):258-264.   Published online 2013 July 4     DOI: http://dx.doi.org/10.3802/jgo.2013.24.3.258
      
17 Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status
Luis Felipe Sallum, Luis Otavio Sarian, Liliana Lucci De Angelo Andrade, José Vassallo, Fernando Augusto Soares, Glauce Aparecida Pinto, Patrícia Andréia Ferreira, Sophie Derchain
J Gynecol Oncol.2013;24(2):167-176.   Published online 2013 April 5     DOI: http://dx.doi.org/10.3802/jgo.2013.24.2.167
      
18 The effects of selenium on tumor growth in epithelial ovarian carcinoma
Jin Sun Park, Ji Yoon Ryu, Hye-Kyung Jeon, Young Jae Cho, Young Ae Park, Jung-Joo Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
J Gynecol Oncol.2012;23(3):190-196.   Published online 2012 July 2     DOI: http://dx.doi.org/10.3802/jgo.2012.23.3.190
      
19 Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?
Joseph Menczer, Irena Usviatzov, Erez Ben-Shem, Abraham Golan, Tally Levy
J Gynecol Oncol.2011;22(3):183-187.   Published online 2011 September 28     DOI: http://dx.doi.org/10.3802/jgo.2011.22.3.183
      
20 Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy
Joseph Menczer, Angela Chetrit, Siegal Sadetzki,
J Gynecol Oncol.2010;21(3):191-195.   Published online 2010 September 28     DOI: http://dx.doi.org/10.3802/jgo.2010.21.3.191
      

 1 of 2